EDITORIAL
Published on 30 Aug 2022
Editorial: Immunosenescence and multiple sclerosis: Prognostic and therapeutic implications
doi 10.3389/fneur.2022.996342
- 1,154 views
- 2 citations
- Frontiers in Neurology
- Multiple Sclerosis and Neuroimmunology
- Research Topics
- Immunosenescence and Multiple Sclerosis: Prognostic and Therapeutic Implications
Immunosenescence and Multiple Sclerosis: Prognostic and Therapeutic Implications
17k
Total Downloads
69k
Total Views and Downloads
Submit your idea
Select the journal/section where you want your idea to be submitted:
Articles
MINI REVIEW
Published on 31 Mar 2022
Efficacy of Disease Modifying Therapies in Progressive MS and How Immune Senescence May Explain Their Failure
doi 10.3389/fneur.2022.854390
- 3,274 views
- 13 citations
ORIGINAL RESEARCH
Published on 11 Mar 2022
Aging With Multiple Sclerosis: Age-Related Factors and Socioeconomic Risks
doi 10.3389/fneur.2022.818652
- 3,105 views
- 8 citations
MINI REVIEW
Published on 10 Mar 2022
Late-Onset MS: Disease Course and Safety-Efficacy of DMTS
doi 10.3389/fneur.2022.829331
- 19,696 views
- 34 citations
REVIEW
Published on 25 Feb 2022
Molecular Mechanisms of Immunosenescene and Inflammaging: Relevance to the Immunopathogenesis and Treatment of Multiple Sclerosis
doi 10.3389/fneur.2021.811518
- 6,833 views
- 31 citations
ORIGINAL RESEARCH
Published on 03 Feb 2022
Characterization of Antigen-Induced CD4+ T-Cell Senescence in Multiple Sclerosis
doi 10.3389/fneur.2022.790884
- 2,641 views
- 8 citations
PERSPECTIVE
Published on 25 Jan 2022
Evolution of Disease Modifying Therapy Benefits and Risks: An Argument for De-escalation as a Treatment Paradigm for Patients With Multiple Sclerosis
doi 10.3389/fneur.2021.799138
- 8,958 views
- 25 citations
ORIGINAL RESEARCH
Published on 13 Jan 2022
Disease-Modifying Drug Uptake and Health Service Use in the Ageing MS Population
doi 10.3389/fimmu.2021.794075
- 1,882 views
- 9 citations
ORIGINAL RESEARCH
Published on 24 Dec 2021
Integrated Lymphopenia Analysis in Younger and Older Patients With Multiple Sclerosis Treated With Cladribine Tablets
doi 10.3389/fimmu.2021.763433
- 4,653 views
- 5 citations
ORIGINAL RESEARCH
Published on 15 Dec 2021
Clinical and Radiological Characteristics of Children and Adults With First-Attack Myelin Oligodendrocyte Glycoprotein Antibody Disease and Analysis of Risk Factors for Predicting the Severity at Disease Onset in Central China
doi 10.3389/fimmu.2021.752557
- 1,670 views
- 9 citations
REVIEW
Published on 01 Dec 2021
Immunosenescence and Autoimmunity: Exploiting the T-Cell Receptor Repertoire to Investigate the Impact of Aging on Multiple Sclerosis
doi 10.3389/fimmu.2021.799380
- 4,417 views
- 16 citations
MINI REVIEW
Published on 05 Nov 2021
Impact of Andropause on Multiple Sclerosis
doi 10.3389/fneur.2021.766308
- 4,644 views
- 5 citations
Published in
Frontiers in Neurology
- Multiple Sclerosis and Neuroimmunology
Participating Journals
Frontiers in Immunology
- 5.7 impact factor
- 9.8 citescore
Impact
- 69kTopic views
- 50kArticle views
- 17kArticle downloads